In this article, we will look at the 10 Best All-Time High Stocks to Buy According to Analysts.
On July 31, Mike Wilson, Morgan Stanley’s chief US equity strategist, joined CNBC Television to discuss the market performance amidst inflation concerns. While many investors and analysts are worried about the impact of inflation on the market, Wilson remains optimistic about the markets. He noted that, as equity strategists, the most important indicator is earnings, which are currently showing a straight upward trend. He highlighted that earnings revision breadth is a V-shaped recovery, which shows what the companies are dealing with right now and how the earnings are going to look in the future. Currently, the earnings revision breadth shows positive signs for companies for the next 6 to 12 months.
Wilson elaborated that this does not mean that tariffs are not going to impact the GDP or the economy. It simply means that the markets have already accounted for the tariff and inflation-related news during the first quarter of 2025, when the earnings revision breadth was terrible. He also noted that while there might be a pause in stock performance during the third quarter of 2025, he remains confident that his earnings forecasts are too low for 2026. Wilson believes that the S&P 500 can reach 7200 in the next 12 months, driven by earnings.
With that, let’s take a look at the 10 best all-time high stocks to buy according to analysts.
Close-up shot of a ticker board reflecting the companies stocks in the stock exchange.
Our Methodology
To curate the list of 10 best all-time high stocks to buy according to analysts, we used the Finviz stock screener, CNN, and Investing.com. Using the screener, we aggregated a list of stocks trading close to their all-time high (0%-10% below high) with analysts still expecting more than 20% upside. Next, we cross-checked the all-time high prices of each stock from Investing.com and the analyst upside potential from CNN. Lastly, we ranked the stocks in ascending order of the analyst upside and also added the number of hedge fund holders for each stock, sourced from Insider Monkey’s Q1 2025 database. Please note that the data was recorded on July 30, 2025.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here).
10 Best All-Time High Stocks to Buy According to Analysts
10. Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)
Price: $85.63
All-Time High: $94.80
Number of Hedge Fund Holders: 47
Analyst Upside Potential: 20.87%
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) is one of the Best All-Time High Stocks to Buy According to Analysts. On July 28, Whitney Ijem from Canaccord Genuity maintained a Buy rating on Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) with a price target of $105.
The analyst highlighted a recent survey of healthcare professionals, which shows high expectations of a rapid adoption of the company’s setmelanotide. The survey predicts a penetration rate of 51% by the third year of its launch. Ijem believes this presents significant upside for the company.
Moreover, new dosing options like oral pills or once-weekly shots are also likely to increase setmelanotide’s appeal as they are easier to administer compared to daily doses. The stock has already surged more than 54% this year and is trading close to its all-time high. Ijem believes there’s more room for growth.
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) is a commercial-stage biopharmaceutical company that develops precision medicines for rare genetic diseases of obesity.
9. Formula One Group (NASDAQ:FWONA)
Price: $90.89
All-Time High: $96.40
Number of Hedge Fund Holders: 22
Analyst Upside Potential: 21.03%
Formula One Group (NASDAQ:FWONA) is one of the Best All-Time High Stocks to Buy According to Analysts. On July 22, Guggenheim raised the firm’s price target on Formula One Group (NASDAQ:FWONA) from $104 to $122, while keeping a Buy rating on the stock.
The firm noted that it updated the model on Formula One Group (NASDAQ:FWONA) to include the company’s acquisition of MotoGP. The company completed the acquisition of MotoGP on July 3. The firm noted that it sees continued momentum for the company heading into the second half of 2025.
Moreover, Formula One Group (NASDAQ:FWONA) announced some strategic advancements during its fiscal first quarter of 2025. The company renewed agreements for key Formula 1 events, including the Mexico Grand Prix through 2028 and the Miami Grand Prix through 2041. In addition, the company also secured new sponsorship partnerships with Barilla Pasta and PwC.
Formula One Group (NASDAQ:FWONA) is part of the Liberty Media Corporation. The group includes global motorsport assets like Formula 1 and MotoGP, while the Liberty Live Group holds interests in live entertainment, including Live Nation and ticketing services.
8. MercadoLibre, Inc. (NASDAQ:MELI)
Price: $2,384.90
All-Time High: $2,645.22
Number of Hedge Fund Holders: 108
Analyst Upside Potential: 21.60%
MercadoLibre, Inc. (NASDAQ:MELI) is one of the Best All-Time High Stocks to Buy According to Analysts. On July 28, Scotiabank analyst Hector Maya initiated coverage on MercadoLibre, Inc. (NASDAQ:MELI) with a Buy rating and a $3,500 price target.
The analyst calls the stock “LatAm Retail Top Pick,” noting that the company has built a peerless moat with its more than 25 years of investment in Latin America. Analyst Maya noted that the company has built a network of unmatched logistics and technological capabilities that enable the company to enjoy a peerless market.
Moreover, the analyst also believes that MercadoLibre, Inc. (NASDAQ:MELI) is uniquely positioned to lead the ongoing shift from physical retail to online shopping in Latin America, which justifies the firm’s highest on-the-street target for the stock.
MercadoLibre, Inc. (NASDAQ:MELI) is a leading e-commerce platform in Latin America, operating in around 18 countries. The company provides an ecosystem of services, including Mercado Pago, Mercado Envios, Mercado Ads, and Mercado Shops.
7. Mueller Industries, Inc. (NYSE:MLI)
Price: $87.92
All-Time High: $89.04
Number of Hedge Fund Holders: 31
Analyst Upside Potential: 24.55%
Mueller Industries, Inc. (NYSE:MLI) is one of the Best All-Time High Stocks to Buy According to Analysts. On July 22, Mueller Industries, Inc. (NYSE:MLI) reported results for its fiscal second quarter of 2025.
The company delivered strong results for the quarter, driven by increased raw material costs. Mueller Industries, Inc. (NYSE:MLI) delivered a net income of $245.9 million, including a $36.3 million gain from an insurance claim tied to a tornado in March 2023. The net income reflected a significant increase year-over-year against the net income of $160.2 million in Q2 2024. Moreover, the net sales also grew by 14.07% during the same time to reach $1.14 billion. The management noted that the higher sales were driven by the acquisitions made in 2024 and a 3.7% increase in copper prices during the quarter.
Mueller Industries, Inc. (NYSE:MLI) manufactures and sells copper, brass, aluminum, and plastic products used in various industries.
6. Nutanix, Inc. (NASDAQ:NTNX)
Price: $75.55
All-Time High: $77.62
Number of Hedge Fund Holders: 54
Analyst Upside Potential: 25.74%
Nutanix, Inc. (NASDAQ:NTNX) is one of the Best All-Time High Stocks to Buy According to Analysts. On July 15, Nutanix, Inc. (NASDAQ:NTNX) released its seventh annual Financial Services Enterprise Cloud Index report.
The report highlighted that almost all financial organizations are now using generative AI applications, mainly to improve customer support, content creation, and fraud detection. However, many organizations are facing challenges, including a lack of skilled workers to manage AI with current systems. Moreover, around 97% of the respondents believe they could do more to secure their GenAI models and applications.
The report also highlights that 92% say they need to modernize their IT infrastructure to support cloud native apps and containers. In addition, the report also highlighted that these containers and hybrid clouds are generating measurable ROI. The survey polled 1,500 tech leaders in financial services worldwide during Fall 2024.
Nutanix, Inc. (NASDAQ:NTNX) is a technology company that provides a cloud software platform to help organizations run and manage applications in multiple environments.
5. News Corporation (NASDAQ:NWSA)
Price: $29.22
All-Time High: $30.75
Number of Hedge Fund Holders: 54
Analyst Upside Potential: 26.63%
News Corporation (NASDAQ:NWSA) is one of the Best All-Time High Stocks to Buy According to Analysts. On July 22, News Corporation (NASDAQ:NWSA) announced that it will release fourth-quarter and full year financial results for 2025 on August 5.
The company delivered robust results in the fiscal third quarter of 2025. Its quarterly revenue increased 1% year-over-year to reach $2.01 billion. Notably, the net income from operations grew 67% to $107 million. Management noted that the growth was driven by strong performance in Dow Jones, Digital Real Estate Services, and Book Publishing. Moreover, in the previous quarter, the company also completed its sale of Foxtel Group to DAZN. This was done to strengthen the company’s focus on core segments.
News Corporation (NASDAQ:NWSA) is a diversified media and information services company that operates in several segments, including digital real estate services, news media, book publishing, and business information.
4. Equitable Holdings, Inc. (NYSE:EQH)
Price: $51.70
All-Time High: $56.61
Number of Hedge Fund Holders: 49
Analyst Upside Potential: 26.69%
Equitable Holdings, Inc. (NYSE:EQH) is one of the Best All-Time High Stocks to Buy According to Analysts. On July 28, Equitable Holdings, Inc. (NYSE:EQH) announced the integration of a new API from Employee Navigator into its EB360 employee benefits platform.
This new update will allow brokers to create and configure employee benefits plans automatically, cutting out manual data entry. The API is available after brokers complete the first step in the company’s digital onboarding process. The new API builds on Equitable Holdings, Inc. (NYSE:EQH)’s Digital Onboarding solution launched in 2023. That solution saw strong adoption, with more than two-thirds of brokers choosing it, where 89% reported quicker implementations, and 97% noted doing business with Equitable was easy.
Equitable Holdings, Inc. (NYSE:EQH) is a diversified financial services company that offers retirement planning, asset management, and wealth management products and services.
3. HEICO Corporation (NYSE:HEI-A)
Price: $256.09
All-Time High: $258.75
Number of Hedge Fund Holders: 65
Analyst Upside Potential: 31.79%
HEICO Corporation (NYSE:HEI-A) is one of the Best All-Time High Stocks to Buy According to Analysts. On July 24, HEICO Corporation (NYSE:HEI-A) announced the acquisition of Gables Engineering, which is a company specializing in advanced avionics controls like navigation, audio, and communication panels for aircraft.
The transaction was completed for cash; however, further details of the transaction were not disclosed by the company. Gables Engineering has over 200 employees and is recognized for its innovations in aviation, including the touchscreen cockpit displays for the Boeing 737 MAX. HEICO Corporation (NYSE:HEI-A) expects this move to boost its earnings within a year.
HEICO Corporation (NYSE:HEI-A) is an aerospace and defense company that operates through Flight Support Group and Electronic Technologies Group.
2. ABIVAX Société Anonyme (NASDAQ:ABVX)
Price: $69.80
All-Time High: $72.90
Number of Hedge Fund Holders: 20
Analyst Upside Potential: 36.10%
ABIVAX Société Anonyme (NASDAQ:ABVX) is one of the Best All-Time High Stocks to Buy According to Analysts. On July 29, Piper Sandler raised the firm’s price target on ABIVAX Société Anonyme (NASDAQ:ABVX) from $70 to $112, while keeping an Overweight rating on the stock.
The upgraded price target comes after the firm analysed Phase 3 induction data for ABIVAX Société Anonyme’s (NASDAQ:ABVX) drug Obefazimod in ulcerative colitis. The firm also noted that it is fair to add the revenue potential from early-line UC treatments, which doubles its US UC revenue forecast to €2,656 million by 2035.
The analyst believes there is significant upside for the ABIVAX Société Anonyme (NASDAQ:ABVX) ahead of key upcoming data releases. This includes full induction data presentations and maintenance data expected in 2026.
ABIVAX Société Anonyme (NASDAQ:ABVX) is a clinical-stage biotechnology company that develops treatments for chronic inflammatory diseases like ulcerative colitis and Crohn’s disease.
1. Merus N.V. (NASDAQ:MRUS)
Price: $65.92
All-Time High: $67.25
Number of Hedge Fund Holders: 53
Analyst Upside Potential: 37.29%
Merus N.V. (NASDAQ:MRUS) is one of the Best All-Time High Stocks to Buy According to Analysts. On June 10, Tazeen Ahmad from Bank of America Securities maintained a Buy rating on Merus N.V. (NASDAQ:MRUS), with a $92 price target.
The analyst noted that a key trial is the ongoing Phase 2 study of Petosemtamab for metastatic colorectal cancer. This trial focuses on different groups of patients with specific genetic types who have not had EGFR treatment before. Ahmad noted that this step-by-step approach would enable the company to better identify responsive patients and is crucial due to the sizable market potential of metastatic colorectal cancer.
Moreover, the treatment works by targeting two molecules, EGFR and LGR5, which allows the drug to fight cancer stem cells. In addition to this, the company is also moving forward with a Phase 3 trial for Petosemtamab in head and neck squamous cell carcinoma. The analyst noted that the interim results suggest that the treatment has the potential to become first in line.
Merus N.V. (NASDAQ:MRUS) is a biotechnology company based in the Netherlands. The company focuses on creating advanced cancer treatments using its unique Multiclonics technology.
While we acknowledge the potential of MRUS to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than MRUS and that has 100x upside potential, check out our report about this cheapest AI stock.
READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money.
Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.
